Farid Frederick Manshadi, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 36 W Park Ln, Waterloo, IA 50701 Phone: 319-234-0109 |
Md Alal Uddin, M.D Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3421 W 9th St, Waterloo, IA 50702 Phone: 319-272-8000 |
Dr. Barbara J Malicka-rozek, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3421 W 9th St, Suite 100, Waterloo, IA 50702 Phone: 319-272-7469 Fax: 319-272-7868 |
Dr. Joseph T. Nora, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3421 W 9th St, Suite 100, Waterloo, IA 50702 Phone: 319-272-7469 Fax: 319-272-7868 |
Dr. Mahesh Mohan, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2710 Saint Francis Dr Ste 419, Waterloo, IA 50702 Phone: 319-272-5000 Fax: 319-272-6724 |
News Archive
A team of researchers from various institutions within the Netherlands examined the use of targeted MS-based proteomics for the detection of SARS-CoV-2 in research and clinical samples.
Veterans who sustained major limb injuries during combat reported little improvement in symptoms of depression, anxiety, post-traumatic stress disorder and other mental-health problems up to 2 years post injury, according to research presented today.
The London Clinic is one of the first hospitals in the UK to offer prostate artery embolization, a new procedure for non-cancerous enlargement of the prostate, a very common condition in older men.
By seeing what substances and molecules affect the development of our diseases, we can develop drugs that prevent or cure diseases. In her dissertation at Kalmar University in Sweden, Ann Novotny has found that the signal molecule acetylcholine (ACh) is important for the progress of cancer of the large intestine and colon, knowledge that is important to factor in when developing drugs that block the effects of Ach on tumor cells.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that results from the IAP311 study have been published in Anesthesiology.
› Verified 3 days ago